|
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not
intended to be used as a source of information on on healthcare or medicines.
The web pages are not kept up to date and are for demonstration purposes only.
For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines
or the package leaflet of your medicine. For up-to-date information on other
healthcare topics, please consult the relevant reliable sources or an healthcare
expert, such as a physician etc.
|
BACK TO LIST |
European Patient Summary
|
|
|
|||||||||||||||||||
Problem list
| Condition | Onset Date | Status |
|---|---|---|
| Osteoporosis | 24-Feb-2021 | active |
| Chronic kidney disease stage 2 | 05-Sep-2018 | active |
| Microalbuminuria due to type 2 diabetes mellitus | 05-Sep-2018 | active |
| Essential hypertension | 05-Jul-2017 | active |
| Hyperglycemia | 05-Jul-2017 | active |
| Disorder of kidney due to diabetes mellitus | 05-Jul-2017 | active |
| Metabolic syndrome X | 05-Jul-2017 | active |
| Hypertriglyceridemia | 05-Jul-2017 | active |
| Ischemic heart disease | 05-Jul-2017 | active |
| Chronic kidney disease stage 1 | 05-Jul-2017 | active |
| Neuropathy due to type 2 diabetes mellitus | 05-Jul-2017 | active |
| Type 2 diabetes mellitus | 29-Jun-2016 | active |
| Osteoarthritis of hip | 18-Feb-1979 | active |
| Sepsis | 07-Jun-1977 | active |
| Prediabetes | 08-Dec-1971 | active |
Medication list
| No known medications |
Immunizations list
| Vaccine | Date |
|---|---|
| Influenza virus antigen only vaccine product | 13-Aug-2024 |
| Clostridium tetani toxoid antigen adsorbed only vaccine product | 17-May-2022 |
| SARS-CoV-2 mRNA vaccine | 02-Mar-2021 |
Procedure History list
| Procedure | Date | Reason |
|---|---|---|
| Depression screening | 04-Jun-2025 | - |
| Assessment of health and social care needs | 04-Jun-2025 | - |
| Assessment using Morse Fall Scale | 04-Jun-2025 | - |
| Depression screening using Patient Health Questionnaire Two-Item score (procedure) | 04-Jun-2025 | - |
| Assessment of anxiety | 22-May-2024 | - |
| Screening for drug abuse | 22-May-2024 | - |
| Screening for domestic abuse | 22-May-2024 | - |
| Assessment of substance use | 22-May-2024 | - |
| Assessment using AUDIT-C (Alcohol Use Disorders Identification Test - Consumption) | 08-May-2024 | - |
| Medication reconciliation | 24-Apr-2024 | - |
| Laparoscopic cholecystectomy | 07-Jul-2021 | - |
| Intubation | 07-Jul-2021 | - |
| Administration of anesthesia for procedure | 07-Jul-2021 | - |
| Ultrasonography of abdomen | 07-Jul-2021 | - |
| Electrocardiographic procedure | 06-Jul-2021 | - |
| Pre-discharge assessment | 04-Mar-2017 | - |
| Discharge from skilled nursing facility (procedure) | 04-Mar-2017 | - |
| Professional / ancillary services care | 03-Mar-2017 | - |
| Nursing care/supplementary surveillance | 03-Mar-2017 | - |
| History AND physical examination | 02-Mar-2017 | - |
| Initial patient assessment | 02-Mar-2017 | - |
| Development of individualized plan of care | 02-Mar-2017 | - |
Allergies and Intolerances
| Allergy/Intolerance | Onset Date | Status | Type | Reaction |
|---|---|---|---|---|
| ? | active | ? |
Care Plan
| Active Planned Care / Goals | Start Date | Reason |
|---|---|---|
| Lifestyle education regarding hypertension | 05-Jul-2017 | Essential hypertension (disorder) |
|
||
| Diabetes self management plan | 08-Dec-1971 | Prediabetes |
|
||
| Immunization Recommendation | Due Date | Reason |
| Vaccine product containing only Influenza virus antigen (medicinal product) | 01-Oct-2025 | Annual seasonal influenza vaccination |
Vital Signs
| Vital Signs | 2025-07-15 | 2025-06-03 |
|---|---|---|
| Body Height | 165.5 cm | 165.5 cm |
| Pain severity - 0-10 verbal numeric rating [Score] - Reported | 2 {score} | 1 {score} |
| Body Weight | 76.8 kg | 76.8 kg |
| Body mass index (BMI) [Ratio] | 28 kg/m2 | 28 kg/m2 |
| Diastolic Blood Pressure | 71 mm[Hg] | 68 mm[Hg] |
| Systolic Blood Pressure | 111 mm[Hg] | 110 mm[Hg] |
| Heart rate | 72 /min | 62 /min |
| Respiratory rate | 14 /min | 15 /min |
Relevant diagnostic tests/laboratory data
| Recent Lab Observations | 16-JUL-2025 | Reference Range | Unit |
|---|---|---|---|
| Glucose [Mass/volume] in Serum or Plasma | 98.4 | 70 - 140 | mg/dL |
| Urea nitrogen [Mass/volume] in Serum or Plasma | 13.8 | 7 - 25 | mg/dL |
| Creatinine [Mass/volume] in Serum or Plasma | 2.1 H | 0.6 - 1.3 | mg/dL |
| Calcium [Mass/volume] in Serum or Plasma | 9.3 | 8.5 - 10.4 | mg/dL |
| Sodium [Moles/volume] in Serum or Plasma | 142.5 | 135 - 145 | mmol/L |
| Potassium [Moles/volume] in Serum or Plasma | 5.0 | 3.5 - 5.1 | mmol/L |
| Chloride [Moles/volume] in Serum or Plasma | 101.7 | 98 - 110 | mmol/L |
| Carbon dioxide, total [Moles/volume] in Serum or Plasma | 20.9 L | 22 - 29 | mmol/L |
| Appearance of Urine | Cloudy urine | ||
| Odor of Urine | Urine smell ammoniacal | ||
| Clarity of Urine | Translucent | ||
| Color of Urine | Brown color | ||
| Glucose [Mass/volume] in Urine by Test strip | 1.5 H | 0.8 - 0 | mg/dL |
| Glucose [Presence] in Urine by Test strip | ++ | ||
| Bilirubin.total [Mass/volume] in Urine by Test strip | 0.3 | 0 - 1 | mg/dL |
| Bilirubin.total [Presence] in Urine by Test strip | Finding of bilirubin in urine | ||
| Ketones [Mass/volume] in Urine by Test strip | 15.0 H | 0 - 4 | mg/dL |
| Ketones [Presence] in Urine by Test strip | Urine ketone test = + | ||
| Specific gravity of Urine by Test strip | 1.0 L | 1.01 - 1.03 | {nominal} |
| pH of Urine by Test strip | 5.4 | 4.5 - 7.5 | pH |
| Protein [Mass/volume] in Urine by Test strip | 313.1 H | 0 - 149 | mg/dL |
| Protein [Presence] in Urine by Test strip | Urine protein test = ++ | ||
| Nitrite [Presence] in Urine by Test strip | Urine nitrite negative | ||
| Hemoglobin [Presence] in Urine by Test strip | Urine blood test = negative | ||
| Leukocyte esterase [Presence] in Urine by Test strip | Urine leukocyte test negative | ||
| Hemoglobin A1c/Hemoglobin.total in Blood | 2.5 L | 3.9 - 5.7 | % |
| Glucose [Mass/volume] in Blood | 98.4 | 70 - 140 | mg/dL |
| Urea nitrogen [Mass/volume] in Blood | 13.8 | 7 - 25 | mg/dL |
| Creatinine [Mass/volume] in Blood | 1.1 | 0.6 - 1.3 | mg/dL |
| Calcium [Mass/volume] in Blood | 9.3 | 8.5 - 10.4 | mg/dL |
| Sodium [Moles/volume] in Blood | 142.5 | 135 - 145 | mmol/L |
| Potassium [Moles/volume] in Blood | 5.0 | 3.5 - 5.1 | mmol/L |
| Chloride [Moles/volume] in Blood | 101.7 | 98 - 114 | mmol/L |
| Carbon dioxide, total [Moles/volume] in Blood | 20.9 L | 22 - 29 | mmol/L |
| Cholesterol [Mass/volume] in Serum or Plasma | 135.2 | 100 - 200 | mg/dL |
| Triglyceride [Mass/volume] in Serum or Plasma | 128.7 | 35 - 175 | mg/dL |
| Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay | 64.8 | 0 - 130 | mg/dL |
| Cholesterol in HDL [Mass/volume] in Serum or Plasma | 44.6 L | 50 - 100 | mg/dL |
| Microalbumin/Creatinine [Mass Ratio] in Urine | 21.3 | 0 - 30 | mg/g |
Device Use
| Device | Date (since) |
|---|---|
| Manual wheelchair (physical object) | 17-Feb-1979 |
| Wheelchair accessory (physical object) | 17-Feb-1979 |
| Blood glucose meter (physical object) | 07-Dec-1971 |